Global Statistics Representing Hemodialysis Market Scenario
Hemodialysis is a treatment therapy to filter water and wastes from blood. Dialysis is the removal of waste products such as creatinine and urea and free water from the blood during kidney failure.
According to the National Chronic Kidney Disease Fact Sheet, 2017, approximately 15% of the U.S. adult population was estimated to suffer from chronic kidney diseases. Diabetes and heart diseases are the prime causes of kidney diseases. Thus, increasing prevalence of diabetes and high blood pressure is expected to contribute to the growing popularity of hemodialysis. According to the National Kidney Foundation, around 10% of the global population is affected by chronic kidney disease (CKD), and millions die every year due to lack of access to affordable treatment.
The global hemodialysis market accounted for over USD 71,501 million in 2017 and is expected to grow at a CAGR of 4.8% during the forecast period, 2019–2026.
The hemodialysis market can be segmented by type, product & service, and end user.
On the basis of type, the market can be segmented into conventional, daily, and nocturnal. The conventional segment is expected to hold a major market share during the forecast period, owing to technological advancements in safe and easy-to-use home dialysis machines.
Based on product and service type, the market can be segmented into equipment, consumable, and drug, and service. The consumable segment is expected to hold a major market share during the forecast period. Increasing demand for peritoneal dialysis, which involves the use of consumables such as catheters, and blood tube sets in the blood purification process and helps in balancing electrolyte levels in the blood is expected to further drive market growth during the forecast period.
On the basis of end user, the market can be segmented into in-center dialysis, hospitals, independent dialysis centers, home dialysis, peritoneal dialysis, and home hemodialysis. Among these, the home dialysis segment is expected to hold a major market share during the forecast period.
Geographically, the global hemodialysis market has been segmented into North America, Europe, Asia- Pacific, and LAMEA.
North America is expected to hold a major market share during the forecast period. According to the National Kidney Foundation, more than 661,000 Americans have experienced kidney failure, of which, 468,000 individuals are on dialysis, and roughly 193,000 live with a functioning kidney transplant.
Europe is expected to be the second largest region in the hemodialysis market. Prevalence of diabetic and heart diseases is a key cause contributing to the increasing incidences of kidney failure. According to the British Heart Foundation, during 2014–2016, over 66,000 died due to coronary heart disease in the U.K. Furthermore, changing eating habits and unhealthy lifestyle are expected to further fuel market growth in years to come.
Asia Pacific is expected to be the fastest growing region in the hemodialysis market. In developing countries such as India, China, and Japan, treatment with dialysis or kidney transplant creates a huge financial burden. Government financial support for kidney transplants is expected to further provide impetus to market growth.
Latin America is projected to achieve stable growth in the hemodialysis market. Hemodialysis treatment is expensive and increasing per capita income, and growing awareness regarding kidney diseases are expected to drive market growth in the Middle East.
Some of the key major players in the hemodialysis market are Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Inc., Cantel Medical Corp., DaVita, Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, and NxStage Medical, Inc. Gambro, Satellite Healthcare, Inc., and MEDIVATORS, Inc.
Hemodialysis Market Segmentation
By Product and Service
By End User
Why buy this report right now?